Abstract
DB Kohn, C Booth, EM Kang. Nature Med. 2020;26(2):200–206 To assess the safety and evaluate the efficacy and stability of ex vivo autologous CD34+ hematopoietic stem and progenitor cell based lentiviral gene therapy for X-linked CGD. This study included 9 male patients with X-CGD (confirmed by DNA sequencing and absent NADPH-oxidase activity) who lacked a 10/10 HLA-matched donor. This is a multicenter prospective study to evaluate the safety and efficacy of lentiviral gene therapy for X-CGD. Patients’ clinical characteristics, laboratory findings …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
